Patent 7429559 was granted and assigned to Takeda Pharmaceutical Company on September, 2008 by the United States Patent and Trademark Office.
A controlled release composition containing a physiologically active substance in high content, suppressing the initial excess release, and achieving a stable release speed over a long period of time is provided.